Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.

Published on Jul 21, 2020in JAMA2.474
· DOI :10.1001/JAMA.2020.10369
Elizabeth Whittaker23
Estimated H-index: 23
(ICL: Imperial College London),
Alasdair Bamford10
Estimated H-index: 10
(GOSH: Great Ormond Street Hospital)
+ 17 AuthorsPerform Consortia1
Estimated H-index: 1
Sources
Abstract
Importance In communities with high rates of coronavirus disease 2019, reports have emerged of children with an unusual syndrome of fever and inflammation. Objectives To describe the clinical and laboratory characteristics of hospitalized children who met criteria for the pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (PIMS-TS) and compare these characteristics with other pediatric inflammatory disorders. Design, Setting, and Participants Case series of 58 children from 8 hospitals in England admitted between March 23 and May 16, 2020, with persistent fever and laboratory evidence of inflammation meeting published definitions for PIMS-TS. The final date of follow-up was May 22, 2020. Clinical and laboratory characteristics were abstracted by medical record review, and were compared with clinical characteristics of patients with Kawasaki disease (KD) (n = 1132), KD shock syndrome (n = 45), and toxic shock syndrome (n = 37) who had been admitted to hospitals in Europe and the US from 2002 to 2019. Exposures Signs and symptoms and laboratory and imaging findings of children who met definitional criteria for PIMS-TS from the UK, the US, and World Health Organization. Main Outcomes and Measures Clinical, laboratory, and imaging characteristics of children meeting definitional criteria for PIMS-TS, and comparison with the characteristics of other pediatric inflammatory disorders. Results Fifty-eight children (median age, 9 years [interquartile range {IQR}, 5.7-14]; 33 girls [57%]) were identified who met the criteria for PIMS-TS. Results from SARS-CoV-2 polymerase chain reaction tests were positive in 15 of 58 patients (26%) and SARS-CoV-2 IgG test results were positive in 40 of 46 (87%). In total, 45 of 58 patients (78%) had evidence of current or prior SARS-CoV-2 infection. All children presented with fever and nonspecific symptoms, including vomiting (26/58 [45%]), abdominal pain (31/58 [53%]), and diarrhea (30/58 [52%]). Rash was present in 30 of 58 (52%), and conjunctival injection in 26 of 58 (45%) cases. Laboratory evaluation was consistent with marked inflammation, for example, C-reactive protein (229 mg/L [IQR, 156-338], assessed in 58 of 58) and ferritin (610 μg/L [IQR, 359-1280], assessed in 53 of 58). Of the 58 children, 29 developed shock (with biochemical evidence of myocardial dysfunction) and required inotropic support and fluid resuscitation (including 23/29 [79%] who received mechanical ventilation); 13 met the American Heart Association definition of KD, and 23 had fever and inflammation without features of shock or KD. Eight patients (14%) developed coronary artery dilatation or aneurysm. Comparison of PIMS-TS with KD and with KD shock syndrome showed differences in clinical and laboratory features, including older age (median age, 9 years [IQR, 5.7-14] vs 2.7 years [IQR, 1.4-4.7] and 3.8 years [IQR, 0.2-18], respectively), and greater elevation of inflammatory markers such as C-reactive protein (median, 229 mg/L [IQR 156-338] vs 67 mg/L [IQR, 40-150 mg/L] and 193 mg/L [IQR, 83-237], respectively). Conclusions and Relevance In this case series of hospitalized children who met criteria for PIMS-TS, there was a wide spectrum of presenting signs and symptoms and disease severity, ranging from fever and inflammation to myocardial injury, shock, and development of coronary artery aneurysms. The comparison with patients with KD and KD shock syndrome provides insights into this syndrome, and suggests this disorder differs from other pediatric inflammatory entities.
Figures & Tables
Download
📖 Papers frequently viewed together
20202.47JAMA
References15
Newest
#1Lucio VerdoniH-Index: 3
#2Angelo MazzaH-Index: 10
Last. Lorenzo D'AntigaH-Index: 27
view all 8 authors...
Summary Background The Bergamo province, which is extensively affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic, is a natural observatory of virus manifestations in the general population. In the past month we recorded an outbreak of Kawasaki disease; we aimed to evaluate incidence and features of patients with Kawasaki-like disease diagnosed during the SARS-CoV-2 epidemic. Methods All patients diagnosed with a Kawasaki-like disease at our centre in the past 5...
Source
#1Russell M Viner (ICH: UCL Institute of Child Health)H-Index: 79
#2Elizabeth Whittaker (Imperial College Healthcare)H-Index: 23
Source
#1Shelley Riphagen (Boston Children's Hospital)H-Index: 3
#2Xabier Gomez (Boston Children's Hospital)H-Index: 1
Last. Paraskevi Theocharis (Boston Children's Hospital)H-Index: 3
view all 5 authors...
Source
#1Stephanie Menikou (ICL: Imperial College London)H-Index: 4
#2Paul R. Langford (ICL: Imperial College London)H-Index: 45
Last. Michael Levin (ICL: Imperial College London)H-Index: 124
view all 3 authors...
Kawasaki disease (KD) is an inflammatory disease in children associated with vasculitis affecting predominantly the coronary arteries, and is now the most common cause of acquired heart disease in children in developed countries. The etiology of KD is unknown but epidemiological studies implicate an infectious agent or toxin, which causes disease in genetically predisposed individuals. The presence of immune complexes (ICs) in the serum of children with KD was established in numerous studies dur...
Source
#1Li Liu (Li Ka Shing Faculty of Medicine, University of Hong Kong)H-Index: 32
#2Qiang Wei (Peking Union Medical College)H-Index: 29
Last. Zhiwei ChenH-Index: 49
view all 19 authors...
: Newly emerging viruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV), Middle Eastern respiratory syndrome CoVs (MERS-CoV), and H7N9, cause fatal acute lung injury (ALI) by driving hypercytokinemia and aggressive inflammation through mechanisms that remain elusive. In SARS-CoV/macaque models, we determined that anti-spike IgG (S-IgG), in productively infected lungs, causes severe ALI by skewing inflammation-resolving response. Alveolar macrophages underwent functional polari...
Source
#1Leah C. Katzelnick (University of California, Berkeley)H-Index: 21
#2Lionel GreshH-Index: 32
Last. Eva Harris (University of California, Berkeley)H-Index: 93
view all 8 authors...
For dengue viruses 1 to 4 (DENV1-4), a specific range of antibody titer has been shown to enhance viral replication in vitro and severe disease in animal models. Although suspected, such antibody-dependent enhancement of severe disease has not been shown to occur in humans. Using multiple statistical approaches to study a long-term pediatric cohort in Nicaragua, we show that risk of severe dengue disease is highest within a narrow range of preexisting anti-DENV antibody titers. By contrast, we o...
Source
#1Tomo Nozawa (YCU: Yokohama City University)H-Index: 8
#2Tomoyuki ImagawaH-Index: 27
Last. Shuichi Ito (YCU: Yokohama City University)H-Index: 31
view all 3 authors...
Four patients with Kawasaki’s disease resistant to IVIG treatment had a response to the anti–interleukin-6 antibody tocilizumab, but coronary-artery aneurysms developed in two of the patients. Such aneurysms occur at very low frequency among patients who receive this treatment.
Source
#1Brian W. McCrindleH-Index: 116
#2Anne H. RowleyH-Index: 49
Last. Elfriede PahlH-Index: 48
view all 14 authors...
Background: Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acqui...
Source
#1Sietse Q. Nagelkerke (UvA: University of Amsterdam)H-Index: 16
#2Taco W. Kuijpers (UvA: University of Amsterdam)H-Index: 80
Intravenous IgG (IVIg) contains polyclonal IgG from thousands of donors. It is administered at a low dose at regular intervals as antibody replacement therapy and at a higher dose as immunomodulatory treatment in various auto-immune or auto-inflammatory diseases. The working mechanism of immunomodulation is not well understood. Many different explanations have been given. During the last decade we have focused on classical antibody binding via the Fc-domain of the IgG molecules to the common IgG...
Source
#1Nazima Pathan (ICL: Imperial College London)H-Index: 17
#2Joanne L. FranklinH-Index: 1
Last. Michael LevinH-Index: 124
view all 11 authors...
Our findings demonstrate an integral role of the p38 mitogen-activated protein kinase pathway in interleukin 6-mediated cardiac contractile dysfunction and inotrope insensitivity. Dysregulation of the p38 mitogen-activated protein kinase pathway in meningococcal septicemia suggests that this pathway may be an important target for novel therapies to reverse myocardial dysfunction in patients with meningococcal septic shock who are not responsive to inotropic support.
Source
Cited By734
Newest
#1Robin Augustine (Qatar University)H-Index: 30
Last. Philip M. Hansbro (UTS: University of Technology, Sydney)H-Index: 68
view all 12 authors...
Abstract null null The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID‐19), has had a dramatic negative impact on public health and economies worldwide. Recent studies on COVID-19 complications and mortality rates suggest that there is a higher prevalence in cardiovascular diseases (CVD) patients. Past investigations on the associations between pre-existing CVDs and susceptibility to coronavirus infections including SARS‐Co...
Source
#1Dongngan T. Truong (Primary Children's Hospital)H-Index: 8
Last. Matthew E. Oster (Emory University)H-Index: 36
view all 17 authors...
ABSTRACT null null Background null The Long-ter M null O U tcomes after the Multisystem Inflammatory null S yndrome null I n null C hildren (MUSIC) study aims to characterize the frequency and time course of acute and long-term cardiac and non-cardiac sequelae in MIS-C, which are currently poorly understood. null null null Methods null This multicenter observational cohort study will enroll at least 600 patients null null null null Conclusions null The MUSIC study, with the largest cohort of MIS...
Source
#1Kyohei Miyamoto (Wakayama Medical University)H-Index: 9
#2Yusuke Koizumi (Wakayama Medical University)
Last. Nobu Fukumoto (Wakayama Medical University)
view all 11 authors...
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticostero...
Source
Last. Rabindra Pratap SinghH-Index: 1
view all 5 authors...
Source
#1Niloufar Yazdanpanah (Tehran University of Medical Sciences)H-Index: 3
#2Nima Rezaei (Tehran University of Medical Sciences)H-Index: 84
Coronavirus disease 2019 (COVID-19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID-19 disease period, there is an accumulating body of evidence concerning the late-onset complications of COVID-19, of which autoimmune manifestations have attracted remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain-Barr...
Source
#1Shampa Sarkar Biswas (Presidency University, Kolkata)
#2Piyali Mazumdar (Presidency University, Kolkata)
Source
#1Jaclyn N Kline (GW: George Washington University)H-Index: 2
#2Sarah Isbey (GW: George Washington University)
Last. Kristen Breslin (GW: George Washington University)H-Index: 10
view all 10 authors...
Objective null To compare clinical and laboratory features of children with Multisystem Inflammatory Syndrome in Children (MIS-C) to those evaluated for MIS-C in the Emergency Department (ED). null Methods null We conducted a retrospective review of the medical record of encounters with testing for inflammatory markers in an urban, tertiary care Pediatric ED from March 1, 2020 to July 31, 2020. We abstracted demographic information, laboratory values, selected medications and diagnoses. We revie...
Source
#1Alicia M. Alcamo (Children's Hospital of Philadelphia)H-Index: 1
#3Hari Krishnan Kanthimathinathan (University of Birmingham)H-Index: 9
Last. Ericka L. Fink (University of Pittsburgh)H-Index: 26
view all 5 authors...
PURPOSE OF REVIEW: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has overwhelmed the global community, negatively impacting patient health and research efforts; associated neurological manifestations are a significant cause of morbidity. This review outlines the worldwide epidemiology of neurologic manifestations of different SARS-CoV-2 clinical pediatric phenotypes, including acute coronavirus disease 2019 (COVID-19), multisystem inflammatory syndrome in children (MI...
Source
Source
#1Heba Mostafa Ahmed (Beni-Suef University)H-Index: 2
#2Rehab Muhammad Abd El Kareem (Beni-Suef University)
Last. Yasmen A. Mohamed (Beni-Suef University)H-Index: 1
view all 5 authors...
During the second wave of COVID-19, there is an increasing incidence of reported cases in children compared to the early wave. Data on the clinical and laboratory characteristics of COVID-19 in children are evolving, and reports on the characteristics and outcomes of severe COVID-19 in children are still under evaluation. We aimed to describe the clinical, laboratory, and radiological characteristics and outcomes of children with COVID-19 infection admitted to the pediatric intensive care unit (...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.